Bryn Mawr Trust CO Adma Biologics, Inc. Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 46 shares of ADMA stock, worth $759. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46Holding current value
$759% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
393Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$308 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$278 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$213 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$189 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$97.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.24B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...